The warning signs include: Severe, worsening abdominal pain that does not resolve Vomiting undigested food many hours after eating (4+ hours) Complete inability to keep food down for more than 24 hours Feeling full after just a few bites consistently across multiple days Visible, persistent abdominal distension that does not fluctuate Unintentional weight loss beyond what is expected from the medication Inability to pass gas or have bowel movements for 3+ days If you experience these symptoms, stop taking semaglutide and contact your healthcare provider immediately
All patients were required to have continuous enrollment of at least 12 months before cohort entry and meet eligibility criteria for one of the five cohort studies defined below (study design diagrams depicted in Supplementary Figs
Food preferences often change without conscious effort
Multiple endocrine neoplasia, type 2 (MEN 2): Drugs containing semaglutide carry a boxed warning for MEN 2
Side effects requiring immediate medical attention include: Severe abdominal pain Persistent vomiting Signs of dehydration Unusual changes in digestion patterns It's essential to note that while side effects may be uncomfortable, they shouldn't automatically lead to discontinuing treatment
The GI effects of semaglutide are dose-dependent